Modulating phosphatase activity in cardiac cells
- 专利权人:
- Roger J. Hajjar
- 发明人:
- Roger J. Hajjar,Federica del Monte,Evangelia Kranias
- 申请号：
- US11662439
- 公开号：
- US09114148B2
- 申请日:
- 2005.09.08
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve β-adrenergic responsiveness.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- R2R1/2 GENE FOR TREATING AND DIAGNOSING CARDIAC AND PULMONARY DISEASES OR CONDITIONS AND CANCER
- Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
- Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin
- METHODS FOR ADMINISTRATION AND METHODS FOR TREATING CARDIOVASCULAR DISEASES WITH RESINIFERATOXIN
- CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES TO RETARD OR REVERSE AGING AND AGE-RELATED DISORDERS
